Cardinal Health Valuation: Undervalued with Modest Discount to Fair Value

Cardinal Health's (CAH) recent share price of $201.11 reflects a 30.33% 3-month return and a 67.50% 1-year total shareholder return, indicating strong momentum. With a revenue of $234.3b and net income of $1.6b, the company's scale in healthcare is attracting attention. The intrinsic value estimate suggests a modest discount, but analysts have a consensus price target of $180.46, framing a discount that hinges on future earnings growth and margin assumptions. The narrative fair value of $216.60 indicates Cardinal Health is undervalued by 7.2%.